Salomé Gallemaers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Salomé Gallemaers has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Chiara Mabiglia
Department of Radiology, Hôpital Universitaire de Bruxelles (HUB)-Erasme, 1070 Brussels, Belgium
1 shared publication - Delphine Martiny
National Reference Centre for Haemophilus influenzae, Laboratoire Hospitalier Universitaire de Bruxelles – Universitair Laboratorium Brussel (LHUB-ULB), Université Libre de Bruxelles (ULB), Brussels, Belgium
1 shared publication - Eva Larranaga Lapique
Departement Clinic of Infectious Diseases, Hôpital Universitaire de Bruxelles (HUB)-Erasme, 1070 Brussels, Belgium
1 shared publication - Maya Hites
Clinic of Infectious Diseases, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), 1070 Brussels, Belgium
1 shared publication - Nicolas Yin
Department of Microbiology, Laboratoire Hospitalier Universitaire de Bruxelles—Universitair Laboratorium Brussel (LHUB-ULB), Université Libre de Bruxelles (ULB), 1000 Brussels, Belgium
1 shared publication - Sophie Schuind
Department of Neurosurgery, Hôpital Universitaire de Bruxelles (HUB), Brussels, Belgium
1 shared publication
Latest Publications
- Open Access
- 30 June 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (7) , 1536
Successful Treatment of Brain Abscess Caused by Nocardia farcinica with Combination Therapy Despite Discrepancies in In Vitro Results: A Case Report and Review of Diagnostic and Therapeutic Challenges
Nocardia spp. is an environmental Gram-positive bacterium able to cause infections in humans, predominantly of an opportunistic nature. Nocardial brain abscesses are rare and result from dissemination from another primary lesion, mainly observed in immunocompromised hosts. The diagnosis of nocardiosis relies on direct examination and bacterial culture, but antimicrobial susceptibility testing (AST) remains controversial due to technical challenges, limited standardization, and a paucity of studies correlating in vitro susceptibility with clinical efficacy. Management is challenging and usually based on expert opinion, as robust evidence is limited. In this case report, we describe an immunocompromised patient with a Nocardia farcinica brain abscess who achieved clinical resolution following combination therapy that included ceftriaxone, despite in vitro resistance, illustrating the complexities in interpreting AST and guiding treatment decisions in rare infections.
- 30 June 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (7) , 1536
Open AccessSuccessful Treatment of Brain Abscess Caused by Nocardia farcinica with Combination Therapy Despite Discrepancies in In Vitro Results: A Case Report and Review of Diagnostic and Therapeutic Challenges
Nocardia spp. is an environmental Gram-positive bacterium able to cause infections in humans, predominantly of an opportunistic nature. Nocardial brain abscesses are rare and result from dissemination from another primary lesion, mainly observed in immunocompromised hosts. The diagnosis of nocardiosis relies on direct examination and bacterial culture, but antimicrobial susceptibility testing (AST) remains controversial due to technical challenges, limited standardization, and a paucity of studies correlating in vitro susceptibility with clinical efficacy. Management is challenging and usually based on expert opinion, as robust evidence is limited. In this case report, we describe an immunocompromised patient with a Nocardia farcinica brain abscess who achieved clinical resolution following combination therapy that included ceftriaxone, despite in vitro resistance, illustrating the complexities in interpreting AST and guiding treatment decisions in rare infections.